Increased incidence of dyspnoea associated with ticagrelor did not appear to adversely affect cardiovascular outcomes in the PLATO study - Storey, RF; Becker, R; Harrington, R
European Society of Cardiology Annual Congress; 2010; Stockholm, Sweden; 2010.